Search results for "Intestinal bacteria"

showing 7 items of 7 documents

Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver

2021

Metastasis is facilitated by the formation of a "premetastatic niche," which is fostered by primary tumor-derived factors. Colorectal cancer (CRC) metastasizes mainly to the liver. We show that the premetastatic niche in the liver is induced by bacteria dissemination from primary CRC. We report that tumor-resident bacteria Escherichia coli disrupt the gut vascular barrier (GVB), an anatomical structure controlling bacterial dissemination along the gut-liver axis, depending on the virulence regulator VirF. Upon GVB impairment, bacteria disseminate to the liver, boost the formation of a premetastatic niche, and favor the recruitment of metastatic cells. In training and validation cohorts of C…

0301 basic medicineCancer ResearchColorectal cancerRegulatorVirulencemedicine.disease_causeMetastasis03 medical and health sciences0302 clinical medicinemedicineHumansNeoplasm MetastasisEscherichia coliBacteriabiologybusiness.industryLiver NeoplasmsDistant recurrencebiology.organism_classificationmedicine.disease030104 developmental biologyLiverOncology030220 oncology & carcinogenesisColonic NeoplasmsCancer researchIntestinal bacteriaNeoplasm Recurrence LocalColorectal NeoplasmsbusinessBacteriaCancer Cell
researchProduct

Relationship between diet, microbiota, and healthy aging

2020

Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/2227-9059/8/8/287 Este artículo pertenece al número especial "Oxidative stress and inflammation: from mechanisms to therapeutic approaches". En este artículo también participan: Marta Inglés, Gloria Olaso, Juan Gambini y Cristina Mas-Bargues. Due to medical advances and lifestyle changes, population life expectancy has increased. For this reason, it is important to achieve healthy aging by reducing the risk factors causing damage and pathologies associated with age. Through nutrition, one of the pillars of health, we are able to modify these factors through modulation of the intestinal microbiota. The Mediterran…

0301 basic medicineMediterranean dietAging.PopulationMedicine (miscellaneous)PhysiologySalud.ReviewNutrition.General Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineMediterranean dietHigh fatmicrobiotaMedicineMicroorganisms.Healthy agingeducationEnvejecimiento.Beneficial effectslcsh:QH301-705.5Dieta mediterraneapolyphenolseducation.field_of_studyOriental dietbusiness.industryaginghealthMicroorganismos.030104 developmental biologynutritionlcsh:Biology (General)Nutrición.Life expectancyIntestinal bacteriaCookery Mediterranean.businessHealth.030217 neurology & neurosurgeryDieta mediterránea.
researchProduct

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin

2009

AIM: To estimate the prevalence of small intestinal bacterial overgrowth (SIBO) in our geographical area (Western Sicily, Italy) by means of an observational study, and to gather information on the use of locally active, non-absorbable antibiotics for treatment of SIBO. METHODS: Our survey included 115 patients fulfilling the Rome II criteria for diagnosis of irritable bowel syndrome (IBS); a total of 97 patients accepted to perform a breath test with lactulose (BTLact), and those who had a positive test, received Rifaximin (Normix®, Alfa Wassermann) 1200 mg/d for 7 d; 3 wk after the end of treatment, the BTLact was repeated. RESULTS: Based on the BTLact results, SIBO was present in about 5…

AdultMalemedicine.medical_specialtyConstipationGastroenterologyRifaximinIrritable Bowel SyndromeLactulosechemistry.chemical_compoundAnti-Infective AgentsGastrointestinal AgentsInternal medicineIntestine SmallSmall intestinal bacterial overgrowthmedicineHumansSicilyIrritable bowel syndromeBreath testSettore MED/12 - GastroenterologiaGastrointestinal agentmedicine.diagnostic_testbusiness.industrydigestive oral and skin physiologyGastroenterologyBacterial InfectionsGeneral Medicinemedicine.diseaseRifamycinsLactuloseRifaximinBrief ArticlesBreath TestschemistryEtiologyFemalemedicine.symptombusinessSIBO rifaximinemedicine.drugWorld Journal of Gastroenterology
researchProduct

Are pathogenic intestinal bacteria present in stool specimens from patients with chronic heart failure?

2018

It has been reported that patients with chronic heart failure exhibit an intestinal overgrowth of primary gut bacterial pathogens, such as Shigella spp., Salmonella spp., Campylobacter spp., and Yersinia enterocolitica. We failed to reproduce these findings in a cohort of 39 patients admitted to the hospital with decompensated heart failure by means of conventional stool bacterial cultures and a multiplexed polymerase chain reaction assay.

MaleMicrobiology (medical)SalmonellaMicrobiological culture030204 cardiovascular system & hematologymedicine.disease_causePolymerase Chain Reactionlaw.inventionMicrobiologyFeces03 medical and health sciences0302 clinical medicineEnterobacteriaceaelawmedicineHumansShigella030212 general & internal medicineYersinia enterocoliticaPolymerase chain reactionAgedAged 80 and overHeart FailureBacteriological Techniquesbiologybusiness.industryCampylobacterCampylobacterGeneral Medicinemedicine.diseasebiology.organism_classificationGastrointestinal MicrobiomeInfectious DiseasesHeart failureChronic DiseaseFemaleIntestinal bacteriabusinessDiagnostic Microbiology and Infectious Disease
researchProduct

Hydrogen- and Methane-Based Breath Testing and Outcomes in Patients With Heart Failure

2019

Background: Recent evidence endorses gut microbiota dysregulation in the pathophysiology of heart failure (HF). Small intestinal bacterial overgrowth (SIBO) might be present in HF and associated with poor clinical outcomes. Lactulose breath testing is a simple noninvasive test that has been advocated as a reliable indicator of SIBO. In patients with HF, we aimed to evaluate the association with clinical outcomes of the exhaled hydrogen (H-2) and methane (CH4) concentrations through the lactulose breath test. Methods and Results: We included 102 patients with HF in which lactulose SIBO breath tests were assessed. Cumulative gas was quantified by the area under the receiver operating characte…

Malemedicine.medical_specialtyheart failuresmall intestinal bacterial overgrowth030204 cardiovascular system & hematologyRate ratioGastroenterologyArticle03 medical and health sciencesLactulose0302 clinical medicineInterquartile rangeInternal medicineIntestine SmallSmall intestinal bacterial overgrowthmedicineHumansGutProspective Studies030212 general & internal medicineAgedAged 80 and overHeart FailureBreath testBacteriamedicine.diagnostic_testReceiver operating characteristicbusiness.industryHazard ratiomedicine.diseaseGastrointestinal MicrobiomeHospitalizationBreath TestsExhalationHeart failureFemalebreath testsprognosisCardiology and Cardiovascular MedicinebusinessMethaneFollow-Up StudiesHydrogenmedicine.drug
researchProduct

From Food Map to FODMAP in Irritable Bowel Sindrome.

2016

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal diseases in the general population, with a prevalence ranging from 12 % to 30 %, mainly affecting younger patients (i.e., <50 years of age) and women [1]. As in other chronic functional gastrointestinal disorders, abdominal discomfort or pain, abnormal bowel habits, and often bloating and abdominal distension are the main clinical features. Their diagnosis is based on symptom patterns (i.e., the Rome III criteria), which also allow categorization in diarrhea-predominant (D-IBS), constipation-predominant (C-IBS), mixed diarrhea and constipation (M-IBS), and unclassified (U-IBS) IBS [2]. Symptom severity ranges from tol…

chemistry.chemical_classificationmedicine.medical_specialtyeducation.field_of_studyConstipationSettore MED/09 - Medicina Internabusiness.industryPopulationIrritable Bowel Sindrome.FODMAPAbdominal distensionmedicine.diseaseFODMAP; Irritable Bowel Sindrome.DiarrheaBloatingchemistryInternal medicineSmall intestinal bacterial overgrowthmedicinemedicine.symptomeducationbusinessFODMAPIrritable bowel syndrome
researchProduct

Clinical case and short review of extreme short bowel syndrome: an update 21 years after

2016

Short bowel syndrome refers to the malabsorptive state caused by loss of significant portions of the small intestine, whose clinical framework is characterized by malnutrition, diarrhea, dehydration, weight loss, and low-weight-related symptoms/signs. These clinical conditions seem to be related to the length of resection. Twenty-one years ago we reported the clinical case of an infant, who underwent a massive resection of the loops of the small intestine, of the cecum and of part of the ascending colon, due to intestinal malrotation with volvulus. The residual small intestine measured just 11 cm and consisted of the duodenum and a small part of jejunum, in the absence of the ileocecal valv…

medicine.medical_specialtySettore MED/09 - Medicina InternaMalabsorptionmalabsorptionlcsh:MedicinemalnutritionGastroenterologyJejunum03 medical and health sciencesIleocecal valve0302 clinical medicineInternal medicineSmall intestinal bacterial overgrowthmedicinesmall intestinal bacterial overgrowth.Ascending colon030212 general & internal medicinebusiness.industryShort bowel syndromelcsh:RGeneral Medicinemedicine.diseaseShort bowel syndromeVolvulusSurgerymedicine.anatomical_structureIntestinal malrotation030211 gastroenterology & hepatologybusinessUltra-short bowel syndromeItalian Journal of Medicine
researchProduct